G. Vernon
Alimentary Pharmacology and Therapeutics · 2011
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom G. Vernon trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Vernon overall
Papers from G. Vernon's perspective
Ordered by how strongly the researchers G. Vernon trusts endorse each paper. Same corpus, a different order for every researcher.
- The prevalence and etiology of elevated aminotransferase levels in the United States (American Journal of Gastroenterology)
- Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy (Annals of Internal Medicine)
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
- Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (Hepatology)
- Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study (Hepatology)
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (Nature Genetics)
- Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. (Gastroenterology)
- Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. (Gastroenterology)
- Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. (Gastroenterology)
- Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. (Journal of Hepatology)